Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Explore this paper's citation graph
Summary
Clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for outpatients with atherothrombosis using simple clinical descriptors.
- Type
- article
- Published
- 2010-09-22
- Cited by
- 709
- References
- 31
- Access
- Open access
- OpenAlex
- https://openalex.org/W2002189205
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:16760369
Keywords
Medicine, Internal medicine, Myocardial infarction, Stroke (engine), Cardiology
References
- Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
- Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
- Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.
- Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not.
- Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
- Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study.
- A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.
- The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
- Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
- Optimizing Trial Design: Sequential, Adaptive, and Enrichment Strategies
- The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.
- One-year cardiovascular event rates in outpatients with atherothrombosis.
- Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results From the Get With the Guidelines Program
- Corrected group prognostic curves and summary statistics.
- Intravenous platelet blockade with cangrelor during PCI.
- Commentary: one-year cardiovascular event rates in outpatients with atherothrombosis. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. JAMA. 2007;297: 1197-1206.
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.
- Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry
- Platelet inhibition with cangrelor in patients undergoing PCI.
Cited by
- Clinical and economic outcomes among elderly myocardial infarction survivors in the United States.
- Lower Extremity Arterial Calcification as a Predictor of Coronary Atherosclerosis in Patients with Peripheral Arterial Disease
- Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
- Variation in CAD Secondary Prevention Prescription among Outpatient Cardiology Practices: Insights from the NCDR®
- Novel Insights in Perioperative Care
- [Aspirin in primary prevention of cardiovascular diseases: how to balance risks and benefits].
- Poly vascular diseaseに対する治療のアプローチ
- Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease.
- El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año
- Atherothrombosis and the role of antiplatelet therapy
- Antithrombotic Therapy for Prevention of Various Thrombotic Diseases
- Polémica con la utilidad de los beta-bloqueadores en prevención secundaria: análisis crítico del registro REACH
- Evidence-based therapy prescription in high-cardiovascular risk patients: the REACT study.
- Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.
- Darapladib for preventing ischemic events in stable coronary heart disease.
- Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry.
- Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective
- Projected Morbidity and Mortality from Missed Diagnoses of Coronary Artery Disease in the United States
- The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization.
- Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine.
Related papers
- Measuring the incidence of acute myocardial infarction: the problem of possible acute myocardial infarction.
- 5-year mortality rate in patients with suspected acute myocardial infarction in relation to early diagnosis.
- Investigation and analysis on the status of diabetes cognition among COPD patients complicated with diabetes mellitus
- Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
- Diabetes status affects long-term changes in coronal caries - The SHIP Study
- Diabetes and life expectancy among Japanese - NIPPON DATA80.
- FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH COVID-19 INFECTION